RELAPSE IN OPIOID USE DISORDER: IMPLICATIONS FOR HEALTH CARE UTILIZATION AND COSTSVALUE IN HEALTHIF62016-05-011OAAI
THE ASSOCIATION BETWEEN BUPRENORPHINE MEDICATION-ASSISTED TREATMENT ADHERENCE AND HEALTH CARE SERVICE UTILIZATION AND COSTSVALUE IN HEALTHIF62016-05-013OAAI
Relationship Between Buprenorphine Adherence and Health Service Utilization and Costs Among Opioid Dependent PatientsJOURNAL OF SUBSTANCE ABUSE TREATMENTIF42014-04-0171PREAI
Concurrent Naltrexone and Prolonged Exposure Therapy for Patients With Comorbid Alcohol Dependence and PTSD A Randomized Clinical TrialJAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATIONIF552013-08-07193PREAI
A Nonopioid Procedure for Outpatient Opioid DetoxificationJOURNAL OF ADDICTION MEDICINEIF3.22011-06-0114PREAI
Combined effects of alcohol and hepatitis C: A secondary analysis of alcohol use biomarkers and high-risk behaviors from two medication trials for alcohol dependenceADDICTIVE BEHAVIORSIF3.62010-02-016OAAI
Alcohol-Induced Disinhibition Expectancies and Impaired Control as Prospective Predictors of Problem Drinking in UndergraduatesPSYCHOLOGY OF ADDICTIVE BEHAVIORSIF2.72009-01-0174OAAI
The Drinking-Induced Disinhibition Scale (DIDS): A measure of three types of disinhibiting effectsADDICTIVE BEHAVIORSIF3.62007-06-0129OAAI